Gorski Lisa A, Hagle Mary E, Bierman Steve
Wheaton Franciscan Home Health & Hospice, Milwaukee, Wisconsin (Ms Gorski); Clement J. Zablocki VA Medical Center, Milwaukee, Wisconsin (Dr Hagle); University of Wisconsin-Milwaukee, Milwaukee, Wisconsin (Dr Hagle); and Access Scientific LLC, San Diego, California (Dr Bierman). Lisa A. Gorski, MS, RN, CRNI®, HHCNS-BC, FAAN, has been a clinical nurse specialist at Wheaton Franciscan Home Health and Hospice in Milwaukee, Wisconsin, since 1985. She served as INS' president from 2007 to 2008 and is the chairperson of INS Standards of Practice Committee. Mary E. Hagle, PhD, RN, FAAN, worked as a clinical nurse specialist in oncology for many years, then as a clinical researcher for the past 14 years. Currently, she is a nurse scientist with Clement J. Zablocki Veterans Affairs Medical Center in Milwaukee and an adjunct clinical assistant professor at the University of Wisconsin-Milwaukee. She is president of the Southeast Wisconsin Chapter of INS and a member of INS' Standards of Practice Committee. Steve Bierman, MD, who is board certified in emergency medicine, family practice, and medical hypnosis, was an emergency physician for 18 years before founding Venetec International in 2001. He is currently founder and chief medical officer of Access Scientific, LLC, in San Diego, California.
J Infus Nurs. 2015 Jan-Feb;38(1):27-46. doi: 10.1097/NAN.0000000000000081.
The Infusion Nurses Society's Infusion Nursing Standards of Practice has treated pH as a critical factor in the decision-making process for vascular access device selection, stating that an infusate with a pH less than 5 or greater than 9 is not appropriate for short peripheral or midline catheters. Because of the Standards, drug pH is not an uncommon factor driving the decision for central vascular access. In this era of commitment to evidence-based practice, the pH recommendation requires reevaluation and a critical review of the research leading to infusate pH as a decisional factor. In this narrative literature review, historical and current research was appraised and synthesized for pH of intermittently delivered intravenous medications and the development of infusion thrombophlebitis. On the basis of this review, the authors conclude and assert that pH alone is not an evidence-based indication for central line placement.
输液护理学会的《输液护理实践标准》将pH值视为血管通路装置选择决策过程中的关键因素,指出pH值小于5或大于9的输注液不适用于外周短导管或中线导管。由于该标准,药物pH值是推动选择中心血管通路的一个常见因素。在这个致力于循证实践的时代,pH值建议需要重新评估,并对导致将输注液pH值作为决策因素的研究进行批判性审查。在这篇叙述性文献综述中,对间歇性静脉给药的pH值和输液性血栓性静脉炎的发展的历史和当前研究进行了评估和综合。基于这一综述,作者得出结论并断言,仅pH值并不是中心静脉置管的循证指征。